MMP9 and cancer: It has been demonstrated that NET-associated serine proteases such as NE could act as alternative enzymes for processing inflammasome-related IL-1β and IL-18, which subsequently leads to the modulation of PGRN inactivation and MMP-9 activation in cancer (114).